vs

Side-by-side financial comparison of Precipio, Inc. (PRPO) and UPEXI, INC. (UPXI). Click either name above to swap in a different company.

UPEXI, INC. is the larger business by last-quarter revenue ($8.1M vs $6.8M, roughly 1.2× Precipio, Inc.). Precipio, Inc. runs the higher net margin — 7.7% vs -2222.1%, a 2229.8% gap on every dollar of revenue. On growth, UPEXI, INC. posted the faster year-over-year revenue change (101.0% vs 28.4%). Precipio, Inc. produced more free cash flow last quarter ($291.0K vs $-2.7M). Over the past eight quarters, Precipio, Inc.'s revenue compounded faster (40.0% CAGR vs 24.2%).

Precipio, Inc. is a specialty diagnostic firm that develops and provides advanced oncology, genetic, and rare disease testing solutions. It primarily serves healthcare providers, clinical laboratories, and patients across the United States, with a core focus on enhancing diagnostic accuracy and improving patient health outcomes.

PRPO vs UPXI — Head-to-Head

Bigger by revenue
UPXI
UPXI
1.2× larger
UPXI
$8.1M
$6.8M
PRPO
Growing faster (revenue YoY)
UPXI
UPXI
+72.6% gap
UPXI
101.0%
28.4%
PRPO
Higher net margin
PRPO
PRPO
2229.8% more per $
PRPO
7.7%
-2222.1%
UPXI
More free cash flow
PRPO
PRPO
$3.0M more FCF
PRPO
$291.0K
$-2.7M
UPXI
Faster 2-yr revenue CAGR
PRPO
PRPO
Annualised
PRPO
40.0%
24.2%
UPXI

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
PRPO
PRPO
UPXI
UPXI
Revenue
$6.8M
$8.1M
Net Profit
$526.0K
$-178.9M
Gross Margin
45.9%
83.3%
Operating Margin
7.9%
-2177.9%
Net Margin
7.7%
-2222.1%
Revenue YoY
28.4%
101.0%
Net Profit YoY
244.1%
-13649.6%
EPS (diluted)
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PRPO
PRPO
UPXI
UPXI
Q4 25
$6.8M
$8.1M
Q3 25
$6.9M
$9.2M
Q2 25
$5.6M
$4.3M
Q1 25
$4.9M
$3.2M
Q4 24
$5.3M
$4.0M
Q3 24
$5.3M
$4.4M
Q2 24
$4.5M
$5.0M
Q1 24
$3.5M
$5.2M
Net Profit
PRPO
PRPO
UPXI
UPXI
Q4 25
$526.0K
$-178.9M
Q3 25
$-79.0K
$66.7M
Q2 25
$74.0K
$-6.9M
Q1 25
$-884.0K
$-3.8M
Q4 24
$-365.0K
$-1.3M
Q3 24
$-626.0K
$-1.6M
Q2 24
$-1.2M
$-15.7M
Q1 24
$-2.1M
$-4.1M
Gross Margin
PRPO
PRPO
UPXI
UPXI
Q4 25
45.9%
83.3%
Q3 25
43.6%
89.6%
Q2 25
43.2%
79.4%
Q1 25
43.6%
49.3%
Q4 24
49.8%
74.3%
Q3 24
43.1%
67.3%
Q2 24
38.1%
31.0%
Q1 24
26.5%
24.3%
Operating Margin
PRPO
PRPO
UPXI
UPXI
Q4 25
7.9%
-2177.9%
Q3 25
-0.9%
Q2 25
-14.6%
-151.7%
Q1 25
-17.5%
-113.5%
Q4 24
-6.3%
-26.8%
Q3 24
-11.3%
-30.6%
Q2 24
-26.8%
-265.2%
Q1 24
-59.6%
-96.5%
Net Margin
PRPO
PRPO
UPXI
UPXI
Q4 25
7.7%
-2222.1%
Q3 25
-1.1%
722.4%
Q2 25
1.3%
-161.5%
Q1 25
-18.0%
-121.2%
Q4 24
-6.9%
-32.5%
Q3 24
-11.9%
-37.3%
Q2 24
-27.1%
-312.4%
Q1 24
-59.8%
-78.9%
EPS (diluted)
PRPO
PRPO
UPXI
UPXI
Q4 25
$0.36
Q3 25
$-0.05
$0.76
Q2 25
$0.05
$0.83
Q1 25
$-0.59
$-2.87
Q4 24
$-0.22
$-1.24
Q3 24
$-0.42
$1.55
Q2 24
$-0.83
$-15.66
Q1 24
$-1.46
$-4.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PRPO
PRPO
UPXI
UPXI
Cash + ST InvestmentsLiquidity on hand
$2.7M
Total DebtLower is stronger
$83.0K
Stockholders' EquityBook value
$14.6M
$48.7M
Total Assets
$21.3M
$271.1M
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PRPO
PRPO
UPXI
UPXI
Q4 25
$2.7M
Q3 25
$2.3M
Q2 25
$1.1M
Q1 25
$1.0M
Q4 24
$1.4M
Q3 24
$1.1M
Q2 24
$1.3M
Q1 24
$776.0K
Total Debt
PRPO
PRPO
UPXI
UPXI
Q4 25
$83.0K
Q3 25
Q2 25
Q1 25
Q4 24
$383.0K
Q3 24
Q2 24
Q1 24
Stockholders' Equity
PRPO
PRPO
UPXI
UPXI
Q4 25
$14.6M
$48.7M
Q3 25
$13.7M
$210.8M
Q2 25
$12.3M
$90.1M
Q1 25
$11.7M
$1.9M
Q4 24
$12.1M
$3.8M
Q3 24
$11.9M
$5.0M
Q2 24
$12.1M
$6.5M
Q1 24
$12.8M
$22.1M
Total Assets
PRPO
PRPO
UPXI
UPXI
Q4 25
$21.3M
$271.1M
Q3 25
$21.2M
$419.7M
Q2 25
$18.8M
$123.8M
Q1 25
$17.8M
$15.1M
Q4 24
$17.0M
$17.5M
Q3 24
$17.0M
$18.6M
Q2 24
$17.3M
$23.5M
Q1 24
$16.6M
$56.5M
Debt / Equity
PRPO
PRPO
UPXI
UPXI
Q4 25
0.01×
Q3 25
Q2 25
Q1 25
Q4 24
0.03×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PRPO
PRPO
UPXI
UPXI
Operating Cash FlowLast quarter
$366.0K
$-2.7M
Free Cash FlowOCF − Capex
$291.0K
$-2.7M
FCF MarginFCF / Revenue
4.3%
-33.5%
Capex IntensityCapex / Revenue
1.1%
0.2%
Cash ConversionOCF / Net Profit
0.70×
TTM Free Cash FlowTrailing 4 quarters
$359.0K
$-22.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PRPO
PRPO
UPXI
UPXI
Q4 25
$366.0K
$-2.7M
Q3 25
$10.0K
$-9.8M
Q2 25
$353.0K
$-8.4M
Q1 25
$-44.0K
$-778.7K
Q4 24
$565.0K
$-1.4M
Q3 24
$41.0K
$-2.0M
Q2 24
$500.0K
$-101.4K
Q1 24
$-667.0K
$783.5K
Free Cash Flow
PRPO
PRPO
UPXI
UPXI
Q4 25
$291.0K
$-2.7M
Q3 25
$-44.0K
$-9.8M
Q2 25
$294.0K
$-8.8M
Q1 25
$-182.0K
$-809.3K
Q4 24
Q3 24
$-68.0K
$-2.1M
Q2 24
$-1.0M
Q1 24
$600.9K
FCF Margin
PRPO
PRPO
UPXI
UPXI
Q4 25
4.3%
-33.5%
Q3 25
-0.6%
-106.0%
Q2 25
5.2%
-205.4%
Q1 25
-3.7%
-25.6%
Q4 24
Q3 24
-1.3%
-49.2%
Q2 24
-20.5%
Q1 24
11.5%
Capex Intensity
PRPO
PRPO
UPXI
UPXI
Q4 25
1.1%
0.2%
Q3 25
0.8%
0.2%
Q2 25
1.0%
9.0%
Q1 25
2.8%
1.0%
Q4 24
0.0%
Q3 24
2.1%
3.8%
Q2 24
18.5%
Q1 24
3.5%
Cash Conversion
PRPO
PRPO
UPXI
UPXI
Q4 25
0.70×
Q3 25
-0.15×
Q2 25
4.77×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons